Miles City Star Alzheimer's drug shows promise in early results of study Custer Country • Sep 29, 2022
Miles City Star Change at the top for Biogen after Alzheimer's drug flops Custer Country • May 4, 2022
Butte Montana Standard The FDA approved a new drug to treat Alzheimer's, but Medicare won't always pay for it -- a doctor explains what researchers know about Biogen's Aduhelm Gold West Country • Apr 14, 2022
Billings Gazette The FDA approved a new drug to treat Alzheimer's, but Medicare won't always pay for it -- a doctor explains what researchers know about Biogen's Aduhelm Custer Country • Apr 14, 2022
Hamilton | Ravalli Republic The FDA approved a new drug to treat Alzheimer's, but Medicare won't always pay for it -- a doctor explains what researchers know about Biogen's Aduhelm Glacier Country • Apr 14, 2022
Sidney Herald Controversial Alzheimer's drug gets limited approval from Medicare Missouri River Country • Apr 11, 2022
Miles City Star Biogen tumbles after Medicare lays out Aduhelm coverage plan Custer Country • Jan 13, 2022